Midgard Science

Labs / Protein production

B

Baopharma 宝济药业

Shanghai, China · baopharma.com

GMP

On your own

Free. Their own form.

Contact Baopharma 宝济药业 directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Baopharma 宝济药业 develops and commercializes recombinant protein and antibody-based therapeutics. It operates in Shanghai, China, with additional affiliated offices in Suzhou, and focuses on drug development, manufacturing, and clinical advancement for biologics and recombinant enzymes.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Recombinant human hyaluronidase solutions

    Develops recombinant human hyaluronidase for subcutaneous drug delivery and combination use with small molecules and biologics.

  • Recombinant IgG cleaving enzyme development

    Develops an IgG-degrading enzyme platform for rapidly lowering IgG in autoimmune disease, transplantation, and gene therapy settings.

  • Recombinant chymotrypsin development

    Uses genetic engineering to develop chymotrypsin products as an alternative to traditional animal organ extraction methods.

  • Bispecific antibody formulation development

    Develops KJ015, an anti-HER2 bispecific antibody formulated with Hysorptase for subcutaneous administration.

  • Biologics manufacturing

    Manufactures therapeutic biological products using mammalian cell expression systems and bacterial/yeast expression systems.

  • Finished dosage form production

    Produces injectable solutions, lyophilized powder injections, and pre-filled syringes.

  • Clinical development support

    Advances products through clinical trial approvals and clinical trial programs in China and other regions.

What they work on

Modalities
Small molecule, Antibody, Bispecific, Recombinant protein
Species and models
mammalian cell expression systems, bacterial expression systems, yeast expression systems, Streptococcus pyogenes
Scale and capacity
approximately 63,000 square meters facility, 94 mu (approx. 15.5 acres) of land, 25,000-square-meter facility
Therapeutic areas
autoimmune diseases, rare diseases, organ transplantation, gene therapy, anti-GBM disease, kidney transplant, HER2-positive cancers, multiple myeloma
Type
CRDMO
Sites
Shanghai, China · Suzhou, China
Quality
cGMP-compliant (manufacturing facility) · Drug Manufacturing License Type A (production of therapeutic biological products (recombinant human hyaluronidase for injection)) · Drug Manufacturing License Type C (manufacture of recombinant human follicle-stimulating hormone-CTP fusion protein injection)
Serves
China, New Zealand
Address
50 Luoxin Road from Shanghai Jingfeng Pharmaceutical Co., Ltd. in October 2021, enab
Founded
2011

Similar labs. AbTherx, Aurigene Pharmaceutical Services, Bio X Cell, Biocytogen

Found in a contract services directory. Listing built from baopharma.com. Work here? Claim this listing.

Baopharma 宝济药业 · Midgard Science